BRCA1 News
The new findings could not only help detect cancers early, but in some cases would enable doctors to detect a tumour before it becomes cancerous.
The study analysed the levels of anti-Mullerian hormone (AMH), an indicator of egg counts, in women with either the BRCA1 or BRCA2 mutation.
The new finding provides at least part of that answer, he said, and could one day translate into better diagnostic and treatment tools for this form of breast cancer.
Loading...